BTK/PI3K delta inhibitors (Curadev)

N/A

Report date: 2025/03/14 16:24:19
NME

Base Information

Drug NameBTK/PI3K delta inhibitors (Curadev)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitorsPhosphatidylinositol 3 kinase delta inhibitors
TargetsTyrosine-protein kinase BTKPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCuradev Pharma Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuradev Pharma Pvt Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A